FILANA THERAPEUTICS, INC.【FLNA】

Market cap

$106.76M

P/E ratio

	Dec 31, 2011	Dec 31, 2012	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Cash and cash equivalents	73	49	49	41	31	17	10	20	23	94	233	201	121	129
Prepaid expenses and other current assets	-	-	-	-	-	-	-	-	-	-	11	10	8	8
Total current assets	98	57	50	41	32	19	11	20	23	94	244	211	130	137
Property and equipment, net	0	-	-	0	0	0	0	0	0	0	21	23	22	21
Intangible assets, net	-	-	-	-	-	-	-	-	-	-	1	1	0	0
Total assets	99	57	50	41	32	19	11	20	23	94	267	235	152	158
Accounts payable and other accrued expenses	-	-	-	-	-	-	-	-	-	-	-	-	11	8
Accrued development expense	-	-	-	-	-	-	-	-	-	-	-	-	3	2
Accrued compensation and benefits	1	1	1	1	1	0	0	0	0	0	2	0	0	1
Other current liabilities	-	-	-	-	-	-	-	-	0	0	1	0	0	0
Total current liabilities	13	10	2	1	3	1	1	1	1	2	13	7	14	12
Other non-current liabilities	-	-	-	-	-	-	-	-	-	-	0	0	-	0
Total liabilities	55	44	2	1	3	1	1	1	1	2	13	7	14	12
Common stock, $0.001 par value; 120,000,000 shares authorized; 48,203,179 and 42,236,919 shares issued and outstanding at December 31, 2024 and 2023, respectively	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Additional paid-in capital	176	149	152	157	160	164	167	184	191	267	461	511	518	551
Retained Earnings (Accumulated Deficit)	-132	-136	-104	-116	-131	-145	-157	-164	-169	-175	-207	-284	-381	-405
Total stockholders' equity	44	13	48	40	29	19	10	20	22	92	254	228	137	146
Total liabilities and stockholders' equity	99	57	50	41	32	19	11	20	23	94	267	235	152	158